|
|
Physicians and scientists working for the Food and Drug Administration (FDA) are being retaliated against for disclosed misconduct within the agency and opposing the improper approval of medical devices. This defiance of law and regulatory protocols has led to unnecessary risks, cancers, and even death. It has also cost the taxpayers millions of dollars in Medicare costs. FDA scientists brave enough to reveal this misconduct have had their careers destroyed.
In October of 2008, a group of eleven FDA scientists and physicians presented their concerns in a letter to Representative John D. Dingell (D-MI), Chairman of the Committee on Energy and Commerce. The letter documents that the agency used intimidation and coercion tactics as a means of getting FDA experts to sidestep scientific regulatory requirements, utilize illegitimate safety evaluation procedures, as well as to accept inaccurate scientific and technical data and conclusions in order to approve medical devices. The FDA managers opted to please industry applicants rather than changing the approval process to better protect the health and safety of all Americans.
This group of distinguished FDA scientists has continued to disclose their concerns to Congress. Some of their concerns have been revealed to the public, including deaths from faulty catheters and patients being overexposed to radiation in CT scans.
As reported in the Washington Post, six current and former employees of the Food and Drug Administration (FDA) have filed a complaint against the FDA in U.S. District Court. The employees are seeking an injunction to stop the agency from illegally spying on employees' private communications to Congress and other oversight agencies
FDA scientists have risked their careers and some have even lost their jobs to raise concerns about our health and safety. The NWC is calling for the FDA to immediately stop spying on and retaliating against whistleblowers.
The Food and Drug Administration denies that it targeted more than five of its scientists or any congressional staff, outside medical experts or journalists in a surveillance operation to identify who leaked confidential information to the media.
Sen. Chuck Grassley, R-Iowa, called on the Justice Department this week to investigate what he deemed the FDA's "targeted spy ring" after thousands of documents collected by the agency's monitoring software was surreptitiously posted online last week, allegedly by accident.
The documents, which were first reported by the New York Times, had been collected from the government-issued computers of five FDA scientists who alleged that the oversight agency was approving medical devises that expose patients to dangerous levels of radiation.
July 18, 2012
July 17, 2012
FDA fires and spies on its own scientists! Atty Stephen Kohn, of Whistleblower fame, who is representing the scientists, gives us the scoop.
By Charles P. Pierce
July 16, 2012
I have a suggestion for the Constitutional Law Professor In Chief.
Knock off this scarifying pissantery. Today.
Outside of its embracing of some — but not all, god knows — of the Bush gang's more outre interpretations of the president's national-security powers, the one thing that could cause me to vote this fall for Dr. Jill Stein, my old fellow fencing parent, is the Obama administration's apparent mania for tracing down leaks, and the administration's increasingly clumsy attempts to explain why they're engaging in formalized Egil Krogh-isms when they get caught out. There is simply no excuse for the continuing treatment of Bradley Manning. Their attitude toward the reporter-source relationship in certain areas is downright alarming. And now this — the Food and Drug Administration has an apparent secret-police function.
By John McQuaid
July 15, 2012
There are a lot of lessons in this New York Times story about ill-starred FDA spying on its own whistleblowing employees. The simplest one is: don’t conduct a spurious, invasive leak investigation and then post the whole thing on the Internet.
Because that appears to be exactly what led to the Times’s expose of the details of the FDA’s fishing expedition: